Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tonsillitis II: Management01:26

Tonsillitis II: Management

363
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
363
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

5.1K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
5.1K
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

3.5K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.5K
Standards of Care II01:19

Standards of Care II

972
Nurses bear specific legal responsibilities under several federal statutes, including:
972
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

242
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
242
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

724
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
724

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Expression and Correlation Analysis of Neuropeptide Family Members in the Peripheral Blood of Patients with COVID-19.

Current pediatric reviews·2026
Same author

A Narrative Review of Dietary Interventions and Supplementation for the Prevention and Treatment of Atopic Dermatitis.

Current pediatric reviews·2026
Same author

Correction: The future of severe acute respiratory syndrome-coronavirus and coronavirus disease.

World journal of pediatrics : WJP·2026
Same author

Infectious associations in childhood Kawasaki Disease.

Current pediatric reviews·2026
Same author

The EAT Algorithm: A Visual Tool to De-escalate Food Avoidance Anxiety in Parents.

Current pediatric reviews·2026
Same author

Adverse Risks for Dermatologists: Insights From Canadian Advertising Medico-Legal Cases.

Journal of cutaneous medicine and surgery·2026
Same journal

Childhood Infectious Encephalitis: An Overview of Clinical Features, Investigations, Treatment, and Recent Patents.

Recent patents on inflammation & allergy drug discovery·2020
Same journal

Nummular Eczema: An Updated Review.

Recent patents on inflammation & allergy drug discovery·2020
Same journal

Childhood Alopecia Areata: An Overview of Treatment and Recent Patents.

Recent patents on inflammation & allergy drug discovery·2020
Same journal

Human Ascariasis: An Updated Review.

Recent patents on inflammation & allergy drug discovery·2020
Same journal

Scenario of the Treatment of Arthritis with Natural Products.

Recent patents on inflammation & allergy drug discovery·2020
Same journal

Acute Myocarditis in Children: An Overview of Treatment and Recent Patents.

Recent patents on inflammation & allergy drug discovery·2020
See all related articles

Related Experiment Video

Updated: Dec 31, 2025

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.1K

Tinea Capitis: An Updated Review.

Alexander K C Leung1, Kam L Hon2, Kin F Leong3

  • 1Department of Pediatrics, The University of Calgary, Alberta Children's Hospital, Calgary, Alberta, Canada.

Recent Patents on Inflammation & Allergy Drug Discovery
|January 8, 2020
PubMed
Summary
This summary is machine-generated.

Tinea capitis, a common fungal scalp infection, requires systemic antifungal treatment for effective management. Combined topical and oral antifungal therapies may improve cure rates and reduce spore transmission.

Keywords:
Alopeciablack dotsdermatophytesfavusfluconazolegriseofulvinitraconazolekerionterbinafine.

More Related Videos

Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus
12:29

Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus

Published on: April 19, 2017

10.6K
Clarifying and Imaging Candida albicans Biofilms
11:09

Clarifying and Imaging Candida albicans Biofilms

Published on: March 6, 2020

12.2K

Related Experiment Videos

Last Updated: Dec 31, 2025

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.1K
Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus
12:29

Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus

Published on: April 19, 2017

10.6K
Clarifying and Imaging Candida albicans Biofilms
11:09

Clarifying and Imaging Candida albicans Biofilms

Published on: March 6, 2020

12.2K

Area of Science:

  • Dermatology
  • Mycology
  • Infectious Diseases

Background:

  • Tinea capitis is a prevalent and often challenging fungal infection affecting the scalp.
  • It commonly impacts children between 3 and 7 years of age.

Purpose of the Study:

  • To provide an updated overview of the evaluation, diagnosis, and treatment of tinea capitis.
  • To discuss recent advancements and therapeutic strategies for this condition.

Main Methods:

  • A comprehensive literature search was conducted using PubMed, focusing on tinea capitis.
  • Included study types were meta-analyses, RCTs, clinical trials, observational studies, and reviews in English.
  • Patent literature was also reviewed for relevant management strategies.

Main Results:

  • Tinea capitis is primarily caused by Trichophyton tonsurans and Microsporum canis.
  • Clinical presentations range from non-inflammatory scaling and alopecia to inflammatory forms like kerion and favus.
  • Dermoscopy, KOH wet mounts, and fungal cultures are key diagnostic tools; mycologic confirmation is recommended before treatment.

Conclusions:

  • Systemic antifungal therapy is essential for treating tinea capitis due to deep-seated infections.
  • Topical antifungals alone are insufficient but can be used adjunctively to reduce transmission and enhance systemic treatment efficacy.
  • Combination therapy with oral and topical antifungals shows promise for increasing cure rates.